Genetic Technologies Limited
(NASDAQ: GENE)
|
4:00 PM EST, 01/22/21 | |||
---|---|---|---|---|
Last: $5.55 | Change: +0.07 | %Change: +1.28% | Volume: 3,023,528 |
Open: | $ 5.38 | Volume: | 3,023,528 | |
---|---|---|---|---|
High: | $ 5.59 | Yield(%) | n/a | |
Low: | $ 5.11 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 76.42M | |
EPS ($) | n/a | Shares Out: | 13.77M |
% Price Change (last 4 weeks): | 56.56 |
---|---|
% Price Change (last 13 weeks): | 61.17 |
% Price Change (last 26 weeks): | 28.34 |
% Price Change (last 52 weeks): | 27.15 |
% Price Change (year to date): | 52.22 |
Return on Equity (%): | -80.14 |
---|---|
Return on Assets (%): | -62.64 |
Return on Invested Capital (%): | -94.74 |
Gross Profit Margin (%): | -4485.32 |
---|---|
Net Profit Margin (%): | -61830.19 |
Operating Profit Margin (%): | -75173.12 |
|
|
50-day Moving Average: | $3.62 |
---|---|
200-day Moving Average: | $3.13 |
Avg. Daily Vol. (last 50 days): | 2,354,538 |
Avg. Daily Vol. (last 200 days): | 3,463,864 |
52-wk high: | $10.30 |
52-wk low: | $1.41 |
Bid: | $5.50 |
Ask: | $5.53 |
Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. It operates through the USA and Australia geographical segments. The firm's product BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
|
Genetic Technologies Limited
60-66 Hanover Street Fitzroy VI 3065 Phone: 61.3.8412.7000 Fax: 61.3.8412.7040 http://www.gtglabs.com |
Earnings (1year) ($): | -0.59 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 0.72 |
Cash Flow ($): | -0.31 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 2387.74 |
Price/Book (x): | 3.19 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 10.81 |
---|---|
Current Ratio (x): | 10.87 |
LT Debt/Equity (x): | 1.85 |
Total Debt/Equity (x): | 3.70 |